JO
AUPH icon

John Overdeck’s Aurinia Pharmaceuticals AUPH Stock Holding History

John Overdeck’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.8M Buy
3,467,514
+38,809
+1% +$620K 0.04% 497
2026
Q1 		$50.8M Buy
3,428,705
+1,465,963
+75% +$21.4M 0.04% 501
2025
Q4 		$31.3M Buy
1,962,742
+621,675
+46% +$8.81M 0.04% 519
2025
Q3 		$14.8M Buy
1,341,067
+1,179,219
+729% +$12.9M 0.02% 768
2025
Q2 		$1.37M Buy
161,848
+54,960
+51% +$441K ﹤0.01% 2068
2025
Q1 		$859K Buy
+106,888
New +$866K ﹤0.01% 2260
2024
Q1 		– Sell
-173,600
Closed -$1.56M – 3031
2023
Q4 		$1.56M Sell
173,600
-454,720
-72% -$3.74M ﹤0.01% 1781
2023
Q3 		$4.88M Sell
628,320
-739,851
-54% -$7.24M 0.01% 916
2023
Q2 		$13.2M Buy
1,368,171
+644,569
+89% +$6.69M 0.03% 531
2023
Q1 		$7.93M Buy
723,602
+98,429
+16% +$867K 0.02% 685
2022
Q4 		$2.7M Buy
625,173
+100,927
+19% +$586K 0.01% 1155
2022
Q3 		$3.94M Buy
+524,246
New +$4.54M 0.01% 843
2020
Q4 		– Sell
-10,899
Closed -$161K – 3323
2020
Q3 		$161K Buy
+10,899
New +$158K ﹤0.01% 2869
2020
Q2 		– Sell
-24,599
Closed -$357K – 2927
2020
Q1 		$357K Buy
+24,599
New +$434K ﹤0.01% 2176
2017
Q2 		– Sell
-548,771
Closed -$4.03M – 2939
2017
Q1 		$4.03M Buy
+548,771
New +$2.53M 0.01% 1047

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

John Overdeck's AUPH Position: Q2 2026 in Review

John Overdeck increased its Aurinia Pharmaceuticals (AUPH) stake by 1.1% in Q2 2026, buying an estimated $620K and bringing the position to 3,467,514 shares worth $58.8M. The position accounts for 0.04% of the portfolio, ranked #497.

John Overdeck first reported a position in AUPH in Q1 2017 and has held it in 15 quarters since. 279 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • John Overdeck held 3,467,514 shares of Aurinia Pharmaceuticals worth $58.8M as of Q2 2026.
  • John Overdeck bought 38,809 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $620K.
  • Aurinia Pharmaceuticals made up 0.04% of John Overdeck's portfolio in Q2 2026, its #497 holding.
  • John Overdeck first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 15 quarters since.
  • 279 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.